Mobile Health Program for Low Blood Sugar Management
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mobile health program called HypoPals, designed to help people with type 1 diabetes better detect and manage low blood sugar levels. Participants will receive various types of text message support, including training on recognizing symptoms and educational content, to determine which is most effective. Individuals who have had type 1 diabetes for at least 5 years, use a continuous glucose monitor, and have experienced severe low blood sugar may be suitable candidates. The goal is to ensure the program runs smoothly and proves helpful before conducting a larger study. As an unphased trial, this study offers a unique opportunity to contribute to the development of innovative tools for diabetes management.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a mobile health program and continuous glucose monitoring, so you may not need to change your medications.
What prior data suggests that the HypoPals mobile health program is safe for managing low blood sugar?
Research shows that specific safety information for the HypoPals mobile health program is not yet available. However, studies on similar smartphone apps for managing diabetes have not identified any major safety issues. These apps typically assist users in controlling blood sugar by offering helpful tips and reminders.
This trial is a pilot study, testing the program's effectiveness and user satisfaction. As the study is in an early stage, safety information may be limited. However, since the program primarily involves sending text messages and providing education, the risks are likely low.
For any concerns about joining, consulting a healthcare provider is advisable. They can help determine if this trial is suitable for you.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Health Program for Low Blood Sugar Management because it offers a fresh approach to managing hypoglycemia using digital tools and education. Unlike standard treatments that typically involve medication and diet adjustments, this trial explores the effectiveness of mobile health interventions like HypoPals. The trial includes innovative strategies such as Hypoglycemia Symptom Detection Training and an Education Plus program, aiming to empower patients with real-time symptom awareness and personalized education. By combining technology with education, these interventions have the potential to enhance self-management and improve outcomes for those experiencing low blood sugar episodes.
What evidence suggests that this trial's treatments could be effective for low blood sugar management?
Research shows that HypoPals, a mobile health program, was designed to help people manage low blood sugar by sending personalized text messages. Although its effectiveness has not been officially tested, it employs methods similar to those proven promising in past studies. This trial includes various treatment arms, such as "Hypoglycemia Symptom Detection Training" and "Education Plus," which may incorporate elements from programs like BGAT and HARPdoc. These programs have helped people recognize symptoms and understand the psychological aspects of health, reducing severe low blood sugar by over 50%. This suggests that HypoPals might enable users to detect and manage symptoms more effectively. The program also uses continuous glucose monitoring systems, which further supports its potential effectiveness.46789
Who Is on the Research Team?
Yu Kuei Alex Lin, MD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for people with Type 1 Diabetes who've had severe low blood sugar in the past year or frequent low sugars, use a Dexcom CGM regularly, have completed diabetes education, and can read English texts. They should be willing to share glucose data and not be pregnant or planning pregnancy soon, have untreated hormonal issues, uncontrolled mental disorders, cognitive dysfunctions or be in other diabetes studies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive basic hypoglycemia education text messages and are randomized to one of four experimental conditions, receiving additional interventional text messages based on their assigned condition.
Follow-up
Participants are monitored for feedback on the helpfulness of message content and overall intervention effectiveness.
What Are the Treatments Tested in This Trial?
Interventions
- HypoPals
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator